Oddity Tech Ltd. (ODD): A Bull Case Theory

Core Thesis - Oddity Tech Ltd. is positioned as a leading player in the beauty and medical-grade healthcare markets, demonstrating consistent execution of its growth strategy [2][5] Financial Performance - In Q2, Oddity achieved a revenue growth of 25% year-over-year, reaching $241 million, and generated $70 million in adjusted EBITDA, with LTM revenue totaling $752 million and $130 million in free cash flow [2][4] - The company's stock was trading at $62.82 with a trailing P/E of 34.90 as of September 12th [1] Business Model and Strategy - Oddity employs a data-driven, direct-to-consumer model that creates a self-reinforcing flywheel, where user insights inform product development, enhancing engagement and generating actionable feedback [3][4] - The upcoming Brand 3 telehealth platform aims to leverage a 60+ million-user base, targeting dermatology to address consumer dissatisfaction with conventional solutions [3][5] Growth Catalysts - Brand 3 and future Brand 4 are expected to be significant growth catalysts, potentially driving revenue growth beyond 25% year-over-year by late 2026 [5] - The company emphasizes sustainable, compounding growth with a target of 20% revenue growth and strong EBITDA margins, resisting short-term pressures [4][5] Market Position and Validation - Despite skepticism from past short reports, Oddity's audited financials, strong Trustpilot scores, and expanding product portfolio validate its business model [4][6] - The valuation appears compelling with significant upside potential driven by continued execution and market expansion [5][6]